Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03611946
What this trial is testing

Safety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve Adults

Who this might be right for
Zika Virus
National Institute of Allergy and Infectious Diseases (NIAID) 56
Early research (Phase 1)Study completedNCT00083603
What this trial is testing

Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 150
Early research (Phase 1)Study completedNCT02337270
What this trial is testing

Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol

Who this might be right for
Tuberculosis
McMaster University 36
Testing effectiveness (Phase 2)Study completedNCT00572910
What this trial is testing

Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis (V710-005)(COMPLETED)

Who this might be right for
Staphylococcus Aureus Infection
Merck Sharp & Dohme LLC 206
Early research (Phase 1)Study completedNCT03035370
What this trial is testing

Viaskin Pertussis Vaccine Trial

Who this might be right for
Whooping Cough
DBV Technologies 102
Testing effectiveness (Phase 2)Study completedNCT04961541
What this trial is testing

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 637
Large-scale testing (Phase 3)Study completedNCT04481191
What this trial is testing

Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)

Who this might be right for
Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9
Merck Sharp & Dohme LLC 400
Large-scale testing (Phase 3)Study completedNCT05975060
What this trial is testing

Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.

Who this might be right for
COVID-19
Novavax 660
Post-approval studies (Phase 4)Study completedNCT03688620
What this trial is testing

Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season

Who this might be right for
Influenza, Human
GlaxoSmithKline 1,060
Testing effectiveness (Phase 2)Study completedNCT02564523
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 1,075
Large-scale testing (Phase 3)Study completedNCT01209780
What this trial is testing

Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age

Who this might be right for
Seasonal Influenza
Novartis Vaccines 3,116
Early research (Phase 1)Study completedNCT01159561
What this trial is testing

Western Equine Encephalitis Vaccine, Inactivated

Who this might be right for
Virus
U.S. Army Medical Research and Development Command 20
Testing effectiveness (Phase 2)Study completedNCT00946179
What this trial is testing

Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 130
Testing effectiveness (Phase 2)Study completedNCT05156723
What this trial is testing

Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.

Who this might be right for
COVID-19Immunologic FactorsCoronavirus Infections+1 more
St. Petersburg Research Institute of Vaccines and Sera 155
Large-scale testing (Phase 3)Study completedNCT03615482
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 1,200
Testing effectiveness (Phase 2)Study completedNCT01397227
What this trial is testing

Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model

Who this might be right for
Malaria
Crucell Holland BV 36
Early research (Phase 1)Study completedNCT01644565
What this trial is testing

Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea

Who this might be right for
Escherichia Coli Infection
U.S. Army Medical Research and Development Command 57
Early research (Phase 1)Study completedNCT06546709
What this trial is testing

DMID 23-0015; Lassa Fever CVD 1000

Who this might be right for
Lassa Fever
Wilbur Chen, MD, MS 54
Early research (Phase 1)Study completedNCT01560793
What this trial is testing

Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years

Who this might be right for
Influenza
VaxInnate Corporation 224
Testing effectiveness (Phase 2)Study completedNCT00263744
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of MEDI-517P in Healthy Adult Female Volunteers Who Are HPV-16 or HPV-18 DNA Positive

Who this might be right for
Healthy
MedImmune LLC 60
Next Page